Novavax, Inc. (NASDAQ:NVAX) is expected to announce second quarter financial results after market close (confirmed) on August 09, 2017. The company added about 60.3% percent in value since last earnings when it was at $0.73. Based on the most relevant historical data, there is a 66 percent probability for share price to go down following the next earnings report. Looking further into earnings reaction history, the stock had moved down 20 times out of last 30 quarters. It has topped earnings-per-share estimates 41% of the time in its last 12 earnings reports. It missed earnings on 6 occasions, and it has met expectations 1 time.
Novavax, Inc. (NASDAQ:NVAX) Earnings Reaction History
Overall, the average earnings surprise was 1.58 percent over the past four quarters. Back on May 11, it posted earnings per share at $-0.16 which topped the consensus $-0.17 projection (Positive surprise of 5.90%). Revenue came in at $5.68M versus consensus estimate of $6.17M. The stock gained 16.44% percent the day following the earnings was released, and on 7th day price change was 49.32% percent.
On February 27, 2017, it posted earnings per share at $-0.21 versus the consensus estimate of $-0.23 (Positive surprise of 8.70%). Revenue of $5.4M was above the $5.45M analysts had expected. The stock gained -7.36% the day following the earnings was released, and on 7th day price change was -9.82%.
On November 09, 2016, it posted earnings per share at $-0.24, topped the consensus estimate of $-0.26 (Positive surprise of 7.70%). Revenue for the quarter was $3.23M while analysts had expected revenues to come in at $3.9M. The stock fell -17.65% the day following the earnings was released, and on 7th day price change was -2.51%.
On August 09, 2016, it posted earnings per share at $-0.29 compared with the consensus estimate of $-0.25 (Negative surprise of -16.00%). That came on revenues of $2.51M for the quarter. Analysts had expected $8.03M in revenue.
Novavax, Inc. (NASDAQ:NVAX) Earnings Expectations
In front of Q3 earnings release, Wall Street is expecting earnings per share of $-0.16. The analysts’ current consensus range is $-0.17-$-0.15 for EPS. The market consensus range for revenue is $5.5M-$6.6M, with an average of $6.02M.
Novavax, Inc. (NASDAQ:NVAX) last closed at $1.21, sending the company’s market cap around $322.22M. The consensus 12-month price target from brokerage firms covering the stock is $3.48 . The share price has declined -85.75% from its best level in 52 weeks and advanced -9.52% this year. It recently traded in a range of $1.17-$1.22 at a volume of 2,345,629 shares. The stock ended last trading session with the price nearly -1.72% lower for the last 5 trading days, rebounding 65.74% from its 52-week low.